Coronary stent Xinsorb®

polymerbioresorbable

Xinsorb® Bioresorbable Sirolimus-eluting Scaffold The final degradation products of the stent are water and carbon dioxide, reducing the risk of late thrombosis. Easy to re-stent even after target lesion restenosis. Completely degradable and resorbable, reducing the risk of foreign body reaction. Help to restore and improve the physiological function of the diseased vessels. Compatible with MRI & CT Indications Patients with myocardial ischemia or angina pectoris caused by coronary artery stenosis or occlusion. Patients with primary or in-situ coronary thrombosis. The diameter of the diseased vessel is between 2.75mm-3.75mm, and the length of the diseased vessel is ≤24mm Patients with probable severe acute occlusion complications after PTCA. Patients with obvious residual stenosis in the lesion after PTCA. Structure The XINSORB® Bioresorbable Sirolimus-eluting Scaffold (hereinafter referred to as XINSORB® Scaffold System) is composed of a balloon-expandable absorbable coronary stent, a drug coating and a delivery system. As shown in the figure. Major structures Balloon-expandable absorbable polymer stent Drug coating Delivery system